Phenylephrine test to better grade mitral valve leak severity
Part of Heart & circulation clinical trials.
This trial tests whether a medication called phenylephrine helps doctors measure how severe mitral regurgitation (mitral valve leak) is. If you’re already scheduled for a special ultrasound from the esophagus, this study may help improve how your valve leak is assessed.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are age 18 or older.
- You have mitral regurgitation (mitral valve leak) seen on your first ultrasound test.
- You are scheduled to get a TEE (an ultrasound probe placed in the esophagus) to further evaluate the leak.
- You must be considered safe enough to have a TEE by your care team.
- You should not have major breathing or circulation instability around the test (your team should judge this).
- Your blood pressure and heart rhythm should be stable enough for the medication test, and you should not have certain serious heart and brain risks.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether using only ultrasound (echo) to guide a mitral valve clip repair is as good as using ultrasound plus X-ray. The study may help patients with a leaky mitral valve who are not good candidates for open heart surgery.
This study looks at how long a new mitral valve treatment/device can stay working in people with moderate-to-severe or severe mitral valve leak. It may help avoid or delay surgery for people considered higher risk for mitral valve repair.
This study looks at how safe and effective a specific catheter procedure is for people with moderate-to-severe mitral valve leakage. It may help those who are considered high risk for traditional open-heart surgery.
This trial tests a new mitral valve device that may improve blood flow in people with significant mitral valve leakage or narrowing, using a catheter instead of open-heart surgery. It’s meant for patients who doctors think this catheter approach is a better fit than surgery.
This trial compares two treatment approaches for people with heart failure and a leaky mitral valve (mitral regurgitation). It aims to find which strategy leads to better outcomes. You may be eligible if your heart function is reduced and you have symptoms despite standard treatments.
This study looks at how symptoms relate to the severity of mitral regurgitation, a leaky heart valve. Researchers want to better understand the link between what you feel and the actual degree of the leak.
Hear when a new Mitral Regurgitation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.